Figure 8 showed that the mRNA expression of predicted target genes (PDCD6, GNG5, PHF6, MAL2, SLC25A15, PTDSS1) were significantly correlated with BLCA individual cancer stages. PDCD6, GNG5, PHF6 and MAL2 as favorable factor for BLCA patients, the high mRNA expressions of them tended to be in stage 1 or 2, whereas the high mRNA expressions of unfavorable factor of SLC25A15 and PTDSS1 tended to be in stage 3 or 4. Similarly, Figure 9 showed that the mRNA expression of predicted target genes (PDCD6, GNG5, PHF6, MAL2, SLC25A15, PTDSS1) were significantly correlated with BLCA molecular subtypes. The gene discussed is PDCD6; the disease is bladder transitional cell carcinoma.